These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

491 related items for PubMed ID: 16343801

  • 1. Supratentorial primitive neuroectodermal tumors (S-PNET) in children: A prospective experience with adjuvant intensive chemotherapy and hyperfractionated accelerated radiotherapy.
    Massimino M, Gandola L, Spreafico F, Luksch R, Collini P, Giangaspero F, Simonetti F, Casanova M, Cefalo G, Pignoli E, Ferrari A, Terenziani M, Podda M, Meazza C, Polastri D, Poggi G, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1031-7. PubMed ID: 16343801
    [Abstract] [Full Text] [Related]

  • 2. Intensive chemotherapy followed by consolidative myeloablative chemotherapy with autologous hematopoietic cell rescue (AuHCR) in young children with newly diagnosed supratentorial primitive neuroectodermal tumors (sPNETs): report of the Head Start I and II experience.
    Fangusaro J, Finlay J, Sposto R, Ji L, Saly M, Zacharoulis S, Asgharzadeh S, Abromowitch M, Olshefski R, Halpern S, Dubowy R, Comito M, Diez B, Kellie S, Hukin J, Rosenblum M, Dunkel I, Miller DC, Allen J, Gardner S.
    Pediatr Blood Cancer; 2008 Feb 15; 50(2):312-8. PubMed ID: 17668858
    [Abstract] [Full Text] [Related]

  • 3. Differential responsiveness among "high risk" pediatric brain tumors in a pilot study of dose-intensive induction chemotherapy.
    Jennings MT, Cmelak A, Johnson MD, Moots PL, Pais R, Shyr Y.
    Pediatr Blood Cancer; 2004 Jul 15; 43(1):46-54. PubMed ID: 15170889
    [Abstract] [Full Text] [Related]

  • 4. No salvage using high-dose chemotherapy plus/minus reirradiation for relapsing previously irradiated medulloblastoma.
    Massimino M, Gandola L, Spreafico F, Biassoni V, Luksch R, Collini P, Solero CN, Simonetti F, Pignoli E, Cefalo G, Poggi G, Modena P, Mariani L, Potepan P, Podda M, Casanova M, Pecori E, Acerno S, Ferrari A, Terenziani M, Meazza C, Polastri D, Ravagnani F, Fossati-Bellani F.
    Int J Radiat Oncol Biol Phys; 2009 Apr 01; 73(5):1358-63. PubMed ID: 19019566
    [Abstract] [Full Text] [Related]

  • 5. Outcome for children <4 years of age with malignant central nervous system tumors treated with high-dose chemotherapy and autologous stem cell rescue.
    Thorarinsdottir HK, Rood B, Kamani N, Lafond D, Perez-Albuerne E, Loechelt B, Packer RJ, MacDonald TJ.
    Pediatr Blood Cancer; 2007 Mar 01; 48(3):278-84. PubMed ID: 16456857
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [High dose chemotherapy with thiotepa, carboplatin, VP16 and autologous stem cell transplantation in treatment of malignant brain tumors with poor prognosis. Results of a mono-center pilot study].
    Fleischhack G, Pöpping K, Hasan C, Utsch B, Jüttner J, Bode U.
    Klin Padiatr; 1998 Mar 01; 210(4):248-55. PubMed ID: 9743961
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Hyperfractionated radiotherapy and chemotherapy for childhood ependymoma: final results of the first prospective AIEOP (Associazione Italiana di Ematologia-Oncologia Pediatrica) study.
    Massimino M, Gandola L, Giangaspero F, Sandri A, Valagussa P, Perilongo G, Garrè ML, Ricardi U, Forni M, Genitori L, Scarzello G, Spreafico F, Barra S, Mascarin M, Pollo B, Gardiman M, Cama A, Navarria P, Brisigotti M, Collini P, Balter R, Fidani P, Stefanelli M, Burnelli R, Potepan P, Podda M, Sotti G, Madon E, AIEOP Pediatric Neuro-Oncology Group.
    Int J Radiat Oncol Biol Phys; 2004 Apr 01; 58(5):1336-45. PubMed ID: 15050308
    [Abstract] [Full Text] [Related]

  • 10. High-dose chemotherapy with autologous stem-cell transplantation and hyperfractionated radiotherapy as first-line treatment of primary CNS lymphoma.
    Illerhaus G, Marks R, Ihorst G, Guttenberger R, Ostertag C, Derigs G, Frickhofen N, Feuerhake F, Volk B, Finke J.
    J Clin Oncol; 2006 Aug 20; 24(24):3865-70. PubMed ID: 16864853
    [Abstract] [Full Text] [Related]

  • 11. Brainstem primitive neuroectodermal tumors (bstPNET): results of treatment with intensive induction chemotherapy followed by consolidative chemotherapy with autologous hematopoietic cell rescue.
    Fangusaro JR, Jubran RF, Allen J, Gardner S, Dunkel IJ, Rosenblum M, Atlas MP, Gonzalez-Gomez I, Miller D, Finlay JL.
    Pediatr Blood Cancer; 2008 Mar 20; 50(3):715-7. PubMed ID: 17009232
    [Abstract] [Full Text] [Related]

  • 12. Hypofractionated stereotactic radiotherapy in the management of recurrent or residual medulloblastoma/PNET.
    Saran F, Baumert BG, Creak AL, Warrington AP, Ashley S, Traish D, Brada M.
    Pediatr Blood Cancer; 2008 Mar 20; 50(3):554-60. PubMed ID: 17941071
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Feasibility of metronomic maintenance chemotherapy following high-dose chemotherapy for malignant central nervous system tumors.
    Choi LM, Rood B, Kamani N, La Fond D, Packer RJ, Santi MR, Macdonald TJ.
    Pediatr Blood Cancer; 2008 May 20; 50(5):970-5. PubMed ID: 17941070
    [Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Outcome of patients with recurrent medulloblastoma or central nervous system germinoma treated with low dose continuous intravenous etoposide along with dose-intensive chemotherapy followed by autologous hematopoietic stem cell rescue.
    Grodman H, Wolfe L, Kretschmar C.
    Pediatr Blood Cancer; 2009 Jul 20; 53(1):33-6. PubMed ID: 19326417
    [Abstract] [Full Text] [Related]

  • 17. Patterns of failure in supratentorial primitive neuroectodermal tumors treated in Children's Cancer Group Study 921, a phase III combined modality study.
    Hong TS, Mehta MP, Boyett JM, Donahue B, Rorke LB, Yao MS, Zeltzer PM.
    Int J Radiat Oncol Biol Phys; 2004 Sep 01; 60(1):204-13. PubMed ID: 15337557
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 25.